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The enzyme porphobilinogen deaminase (PBGD; hydroxymethylbilane
synthase; EC 2.5.1.61) catalyses an early step of the tetrapyrrole-biosynthesis
pathway in which four molecules of the monopyrrole porphobilinogen are
condensed to form a linear tetrapyrrole. The enzyme possesses a dipyrro-
methane cofactor which is covalently linked by a thioether bridge to an invariant
cysteine residue. Expression in Escherichia coli of a His-tagged form of Bacillus
megaterium PBGD permitted the crystallization and preliminary X-ray analysis
of the enzyme from this species at high resolution.
1. Introduction
The enzyme porphobilinogen deaminase (PBGD), which is also
known as hydroxymethylbilane synthase (EC 2.5.1.61), catalyses an
early step of the tetrapyrrole-biosynthesis pathway in which four
molecules of the monopyrrole porphobilinogen are condensed to
form a linear tetrapyrrole, preuroporphyrinogen or hydroxymethyl-
bilane (Fig. 1; Jordan, 1991). Isotopic labelling and single-turnover
studies showed that the pyrrole-forming ring A (Fig. 1) is the first to
bind to the enzyme, followed by rings B, C and finally D. PBGD is a
monomeric protein with a molecular weight in the range 34–44 kDa
depending on the species (Jordan, 1991). The enzyme possesses a
dipyrromethane cofactor (Fig. 2) which is covalently bound to the
enzyme by a thioether linkage involving an invariant cysteine residue
(Jordan & Warren, 1987). The cofactor acts as a primer to which four
porphobilinogen molecules are attached sequentially prior to clea-
vage of the link between the cofactor and the first substrate molecule
on completion of the reaction. Thus, the cofactor remains covalently
attached to the enzyme when the product of the reaction is released.
The X-ray structure of the Arabidopsis thaliana enzyme has
recently been solved (PDB entry 4htg; Roberts et al., 2013); prior
to this, structures were available for Escherichia coli PBGD [PDB
entries 1pda (Louie et al., 1992, 1996), 1gtk (Helliwell et al., 2003),
1ah5 (Ha¨dener et al., 1999), 1ypn (Helliwell et al., 1998) and 2ypn
(Nieh et al., 1999)] and the human enzyme (PDB entries 3eq1 and
3ecr; Gill et al., 2009; Song et al., 2009). The polypeptide is folded
into three domains (1–3), each of approximately the same size. The
general architecture of domains 1 and 2 shows a strong resemblance
to a number of periplasmic binding proteins. The dipyrromethane
cofactor is attached to a loop on domain 3 and is positioned at the
mouth of a deep active-site cleft formed between domains 1 and 2.
The Gram-positive bacterium Bacillus megaterium is of great
industrial interest since it has many commercial applications in the
biotechnological production of numerous substances, including the
tetrapyrrole vitamin B12. Here, we report the expression and crys-
tallization of PBGD from B. megaterium in a form that diffracts
synchrotron radiation to very high resolution.
2. Expression and purification
The B. megaterium PBGD gene was cloned into theNdeI and BamHI
restriction sites of the expression vector pET14b using standard
methods and was transformed into Rosetta (DE3) E. coli cells
(Novagen). Expression was undertaken using 500 ml cultures, which
were grown overnight at 310 K following induction with 0.2 mM
isopropyl -d-1-thiogalactopyranoside (IPTG) at mid-log phase. The
cultures were then centrifuged at 5000 rev min1 for 15 min with a
Beckman Coulter Avanti J-26 XP ultracentrifuge using a JLA-8.1000
rotor to obtain the cell pellet. The 3.75 g pellet obtained from a 1 l
culture was then resuspended in 25 ml 50 mM Tris–HCl buffer pH 8
and sonicated on ice using an MSI Soniprep 150 instrument. The cell
lysate was centrifuged at 12 000 rev min1 using a Beckman JA-25.50
rotor to separate the cell debris from the supernatant. The clear
supernatant was then loaded onto a pre-equilibrated HisTrap HP
(GE Healthcare) 1 ml column, allowing the His-tagged PBGD to
bind prior to washing the column with binding buffer in order to
remove impurities. The enzyme was eluted with a buffer containing
500 mM imidazole and the polyhistidine tag was removed by the
addition of thrombin (one unit per milligram of purified protein)
followed by overnight incubation at room temperature. The cleaved
tag and thrombin were then removed by passing the previously
dialysed protein through a HisTrap HP 1 ml column again followed
by a HiTrap Benzamidine FF 1 ml column (GEHealthcare). The final
yield of purified B. megaterium PBGD was approximately 10–12 mg
per litre of cell culture. Curiously, the cells and purified protein had a
marked pink colouration, although over a period of several weeks the
protein became yellow, presumably owing to slow oxidation of the
cofactor.
3. Crystallization
The purified native PBGD was concentrated to 2.5 mg ml1 using a
Vivaspin centrifugal concentrator and was subjected to screening for
crystallization conditions by use of the hanging-drop method with
Molecular Dimensions Structure Screens I and II. After about
two weeks, yellow crystals appeared in Structure Screen I condition
15 (0.1M sodium cacodylate pH 6.5, 0.2M magnesium acetate, 20%
PEG 8K) at room temperature (Fig. 3). Subsequent optimization
screens revealed that crystals could be obtained reproducibly in 0.1M
sodium cacodylate pH 6.5–6.8, 0.2M magnesium acetate, 25–30%
PEG 8K. Removal of the His tag (as described above) was found to
be necessary to obtain crystals of this enzyme. Selected crystals were
treated by the addition of glycerol to approximately 40%(v/v) before
mounting in loops and flash-cooling with an Oxford Cryosystems
cryocooler.
4. Preliminary X-ray analysis
X-ray data collection using station I03 at the Diamond Light Source
(DLS, Didcot, England) revealed that the B. megaterium PBGD
crystals were of very high diffraction quality (Fig. 4). Using 1
oscillations, 190 of data were collected from a single crystal main-
tained at a temperature of 100 K using a PILATUS 6M-F detector
with an exposure time of 1 s per image (15% transmission) and a
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Figure 1
The reaction catalysed by porphobilinogen deaminase. Four molecules of the
pyrrole porphobilinogen are condensed to form the linear tetrapyrrole preuro-
porphyrinogen (hydroxymethylbilane). The acetic and propionic acid side chains of
each pyrrole are abbreviated A and P, respectively, and the four rings of the
tetrapyrrole product are indicated in italics as A, B, C and D.
Figure 2
The dipyrromethane cofactor of porphobilinogen deaminase is covalently attached
to the enzyme by a thioether bond to a cysteine residue. Four substrate pyrroles are
added linearly to the cofactor and, finally, hydrolysis of the linkage between the
substrate and the cofactor releases the tetrapyrrole product hydroxymethylbilane.
Figure 3
Crystals of B. megaterium PBGD obtained by the hanging-drop method. Their
marked yellow colouration probably arises from oxidation of the dipyrromethane
cofactor. The rather irregular crystal shown here is approximately 0.3 mm in its
longest dimension and was separated into smaller pieces for data collection.
Table 1
Data-collection and processing statistics for B. megaterium PBGD.
Values in parentheses are for the outer resolution shell.
Beamline I03, DLS
Wavelength (A˚) 0.976
Space group P212121
Unit-cell parameters
a (A˚) 53.3
b (A˚) 65.8
c (A˚) 97.2
Mosaic spread () 0.26
Resolution (A˚) 48.60–1.46 (1.53–1.46)
Rmerge† (%) 6.1 (55.9)
Rmeas‡ (%) 6.7 (61.3)
Completeness (%) 100.0 (100.0)
Average I/(I) 14.4 (3.0)
Multiplicity 6.2 (6.0)
No. of observed reflections 378329 (52575)
No. of unique reflections 60772 (8748)
Wilson plot B factor (A˚2) 15.8
Solvent content (%) 53.0
No. of molecules per asymmetric unit 1
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ. ‡ Rmeas =
P
hklfNðhklÞ=
NðhklÞ  1g1=2Pi jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where hI(hkl)i is the mean
intensity of the N(hkl) observations Ii(hkl) of each unique reflection hkl after scaling.
crystal-to-detector distance of 268.8 mm. The incident beam had a
wavelength of 0.976 A˚. Data processing with MOSFLM (Leslie,
2006), SCALA (Evans, 2006) and other programs in the CCP4 suite
(Winn et al., 2011) revealed that the crystals belonged to the mono-
clinic space group P212121, with unit-cell parameters a = 53.3, b= 65.8,
c = 97.2 A˚. Inspection of the correlation coefficient for half-data-set
intensities, as recommended by Karplus & Diederichs (2012) and
Evans (2012), suggests that the diffraction data extend to a resolution
of dmin = 1.46 A˚ with an overall Rmerge of 6.1% and an Rmeas of 6.7%
(for details, see Table 1). By using the method of Matthews (1968), as
implemented by Kantardjieff & Rupp (2003), it was estimated that
the crystals contained a single PBGD monomer per crystallographic
asymmetric unit with a solvent content of 53%. Structure analysis
by use of the molecular-replacement program MOLREP (Vagin &
Teplyakov, 2010) with E. coli PBGD (47% identity; PDB entry 1pda;
Louie et al., 1992) as the search model was successful and refinement
of the B. megaterium PBGD structure is currently in progress using
this high-resolution data set.
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Figure 4
A diffraction image of B. megaterium PBGD obtained on DLS beamline I03 using
a PILATUS 6M-F detector. The diffraction data obtained from this crystal were
processed to a resolution of 1.46 A˚.
